vs
Orthofix Medical Inc.（OFIX）与Westrock Coffee Co（WEST）财务数据对比。点击上方公司名可切换其他公司
Westrock Coffee Co的季度营收约是Orthofix Medical Inc.的1.5倍（$339.5M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -6.6%，领先5.6%），Westrock Coffee Co同比增速更快（48.3% vs 2.0%），Westrock Coffee Co自由现金流更多（$27.8M vs $16.8M），过去两年Westrock Coffee Co的营收复合增速更高（32.8% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Westrock Coffee Co是一家全球化综合咖啡及饮品解决方案供应商，业务覆盖咖啡、茶与功能性饮品的采购、烘焙、生产及分销，为北美及全球其他区域的零售、餐饮和商业客户提供定制化产品及配套服务。
OFIX vs WEST — 直观对比
营收规模更大
WEST
是对方的1.5倍
$219.9M
营收增速更快
WEST
高出46.3%
2.0%
净利率更高
OFIX
高出5.6%
-6.6%
自由现金流更多
WEST
多$11.0M
$16.8M
两年增速更快
WEST
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $339.5M |
| 净利润 | $-2.2M | $-22.6M |
| 毛利率 | 71.1% | 11.5% |
| 营业利润率 | 0.2% | -2.6% |
| 净利率 | -1.0% | -6.6% |
| 营收同比 | 2.0% | 48.3% |
| 净利润同比 | 92.4% | 8.3% |
| 每股收益（稀释后） | $-0.05 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXWEST
| Q4 25 | $219.9M | $339.5M | ||
| Q3 25 | $205.6M | $354.8M | ||
| Q2 25 | $203.1M | $280.9M | ||
| Q1 25 | $193.6M | $213.8M | ||
| Q4 24 | $215.7M | $229.0M | ||
| Q3 24 | $196.6M | $220.9M | ||
| Q2 24 | $198.6M | $208.4M | ||
| Q1 24 | $188.6M | $192.5M |
净利润OFIXWEST
| Q4 25 | $-2.2M | $-22.6M | ||
| Q3 25 | $-22.8M | $-19.1M | ||
| Q2 25 | $-14.1M | $-21.6M | ||
| Q1 25 | $-53.1M | $-27.2M | ||
| Q4 24 | $-29.1M | $-24.6M | ||
| Q3 24 | $-27.4M | $-14.3M | ||
| Q2 24 | $-33.4M | $-17.8M | ||
| Q1 24 | $-36.0M | $-23.7M |
毛利率OFIXWEST
| Q4 25 | 71.1% | 11.5% | ||
| Q3 25 | 72.2% | 11.7% | ||
| Q2 25 | 68.7% | 14.7% | ||
| Q1 25 | 62.8% | 13.6% | ||
| Q4 24 | 69.0% | 16.6% | ||
| Q3 24 | 68.7% | 16.8% | ||
| Q2 24 | 67.8% | 19.9% | ||
| Q1 24 | 67.5% | 19.4% |
营业利润率OFIXWEST
| Q4 25 | 0.2% | -2.6% | ||
| Q3 25 | -8.3% | -2.4% | ||
| Q2 25 | -7.9% | -5.3% | ||
| Q1 25 | -25.2% | -6.1% | ||
| Q4 24 | -5.3% | -4.3% | ||
| Q3 24 | -9.6% | -5.8% | ||
| Q2 24 | -12.5% | -7.9% | ||
| Q1 24 | -15.6% | -5.3% |
净利率OFIXWEST
| Q4 25 | -1.0% | -6.6% | ||
| Q3 25 | -11.1% | -5.4% | ||
| Q2 25 | -6.9% | -7.7% | ||
| Q1 25 | -27.4% | -12.7% | ||
| Q4 24 | -13.5% | -10.7% | ||
| Q3 24 | -13.9% | -6.5% | ||
| Q2 24 | -16.8% | -8.5% | ||
| Q1 24 | -19.1% | -12.3% |
每股收益（稀释后）OFIXWEST
| Q4 25 | $-0.05 | $-0.22 | ||
| Q3 25 | $-0.57 | $-0.20 | ||
| Q2 25 | $-0.36 | $-0.23 | ||
| Q1 25 | $-1.35 | $-0.29 | ||
| Q4 24 | $-0.76 | $-0.26 | ||
| Q3 24 | $-0.71 | $-0.16 | ||
| Q2 24 | $-0.88 | $-0.20 | ||
| Q1 24 | $-0.95 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $49.9M |
| 总债务越低越好 | — | $444.1M |
| 股东权益账面价值 | $450.0M | $-1.9M |
| 总资产 | $850.6M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXWEST
| Q4 25 | $82.0M | $49.9M | ||
| Q3 25 | $62.9M | $34.0M | ||
| Q2 25 | $65.6M | $44.0M | ||
| Q1 25 | $58.0M | $33.1M | ||
| Q4 24 | $83.2M | $26.2M | ||
| Q3 24 | $30.1M | $22.4M | ||
| Q2 24 | $26.4M | $24.3M | ||
| Q1 24 | $27.0M | $12.6M |
总债务OFIXWEST
| Q4 25 | — | $444.1M | ||
| Q3 25 | $157.2M | — | ||
| Q2 25 | $157.0M | — | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | $393.1M | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $118.0M | — | ||
| Q1 24 | $118.2M | — |
股东权益OFIXWEST
| Q4 25 | $450.0M | $-1.9M | ||
| Q3 25 | $442.5M | $11.4M | ||
| Q2 25 | $458.3M | $18.2M | ||
| Q1 25 | $458.3M | $71.4M | ||
| Q4 24 | $503.1M | $97.5M | ||
| Q3 24 | $525.9M | $110.3M | ||
| Q2 24 | $546.0M | $81.5M | ||
| Q1 24 | $570.3M | $91.7M |
总资产OFIXWEST
| Q4 25 | $850.6M | $1.2B | ||
| Q3 25 | $832.6M | $1.2B | ||
| Q2 25 | $837.2M | $1.2B | ||
| Q1 25 | $823.1M | $1.1B | ||
| Q4 24 | $893.3M | $1.1B | ||
| Q3 24 | $867.9M | $1.1B | ||
| Q2 24 | $882.0M | $1.1B | ||
| Q1 24 | $906.0M | $983.3M |
负债/权益比OFIXWEST
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | 4.03× | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $36.7M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $27.8M |
| 自由现金流率自由现金流/营收 | 7.6% | 8.2% |
| 资本支出强度资本支出/营收 | 4.9% | 2.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $-107.8M |
8季度趋势，按日历期对齐
经营现金流OFIXWEST
| Q4 25 | $27.7M | $36.7M | ||
| Q3 25 | $12.4M | $-26.6M | ||
| Q2 25 | $11.6M | $-7.0M | ||
| Q1 25 | $-18.4M | $-22.1M | ||
| Q4 24 | $23.7M | $2.8M | ||
| Q3 24 | $11.7M | $-332.0K | ||
| Q2 24 | $9.0M | $-23.7M | ||
| Q1 24 | $-18.6M | $8.0M |
自由现金流OFIXWEST
| Q4 25 | $16.8M | $27.8M | ||
| Q3 25 | $2.5M | $-44.7M | ||
| Q2 25 | $4.5M | $-27.5M | ||
| Q1 25 | $-25.1M | $-63.4M | ||
| Q4 24 | $15.2M | $-15.4M | ||
| Q3 24 | $6.3M | $-36.7M | ||
| Q2 24 | $-360.0K | $-59.9M | ||
| Q1 24 | $-29.1M | $-60.9M |
自由现金流率OFIXWEST
| Q4 25 | 7.6% | 8.2% | ||
| Q3 25 | 1.2% | -12.6% | ||
| Q2 25 | 2.2% | -9.8% | ||
| Q1 25 | -13.0% | -29.7% | ||
| Q4 24 | 7.0% | -6.7% | ||
| Q3 24 | 3.2% | -16.6% | ||
| Q2 24 | -0.2% | -28.7% | ||
| Q1 24 | -15.4% | -31.7% |
资本支出强度OFIXWEST
| Q4 25 | 4.9% | 2.6% | ||
| Q3 25 | 4.8% | 5.1% | ||
| Q2 25 | 3.5% | 7.3% | ||
| Q1 25 | 3.5% | 19.3% | ||
| Q4 24 | 4.0% | 7.9% | ||
| Q3 24 | 2.7% | 16.5% | ||
| Q2 24 | 4.7% | 17.4% | ||
| Q1 24 | 5.6% | 35.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
